Marsh & McLennan Companies, Inc.

Marsh & McLennan’s recent 10-Q presents a curious case where revenue growth did not translate to operating income expansion. For the three months ended March 31, 2026, revenue increased to $7,597 million from $7,061 million in the prior year. However, operating income — a measure of profit before interest and taxes — declined from $2,005 million to $1,754 million over the same period. This suggests that the cost of generating that additional revenue outpaced the top-line growth, a trend worth examining.

The forensic scores offer a mixed but generally stable picture. Beneish’s 1999 eight-ratio earnings-manipulation detector yielded an M-Score of -2.4721, which does not suggest an elevated risk of earnings manipulation (the threshold for concern is >-1.78). Altman’s Z″ — a 1968 bankruptcy-distress index — registered 1.4, placing the company in the “grey zone” (1.10–2.60), indicating some potential for distress but not immediate alarm. Piotroski’s F-Score, a 9-point fundamental strength scan, came in at a robust 7.0, signaling strong financial health based on profitability, leverage, liquidity, and operating efficiency.

The decline in operating income becomes clearer when examining the expense lines. Other operating expenses saw a notable increase, rising from $1,206 million to $1,713 million year-over-year. This substantial jump, alongside a rise in compensation and benefits, outpaced the revenue growth, directly impacting profitability. The MD&A also highlights the company’s diligent approach to managing “counter-party credit risk” for its cash investments, noting a “Board-approved investment policy” that mandates “preservation of principal and liquidity” through diversification and credit rating limits. This focus underscores the importance of risk management in a financial services context.

This filing provides a snapshot of Marsh & McLennan’s recent operational performance and its approach to financial risk. It details the immediate past, showing revenue growth alongside a contraction in operating income due to rising expenses. What the filing cannot tell us is the future trajectory of these expenses, the effectiveness of the investment policy under unforeseen market conditions, or the broader competitive landscape. It describes the company’s financial condition, but the question of whether the security is mispriced remains outside its scope. Read the 10-Q. Decide for yourself.